Cargando…

1441. Comparison of Cefpodoxime vs. Oral Cefuroxime for Urinary Tract Infections at a Large Academic Medical Center

BACKGROUND: Cefpodoxime (CPD) and cefuroxime (CFX) are both oral cephalosporins indicated for urinary tract infection (UTI) treatment. CPD may have unfavorable pharmacokinetics (PK) given the lesser degree of renal excretion and urine concentration vs. CFX and risk of collateral damage. The objectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bao, Hongkai, Dubrovskaya, Yanina, (Polly) Jen, Shin-Pung, Jie (Cindy) Chen, Xian, Siegfried, Justin, Papadopoulos, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810053/ http://dx.doi.org/10.1093/ofid/ofz360.1305

Ejemplares similares

1072. Streamlining to Oral β-Lactam vs. Fluoroquinolone as Definitive Therapy for Enterobacteriaceae Bacteremia
por: Fong, Karen, et al.
Publicado: (2018)

Clinical Outcomes of Ceftriaxone vs Penicillin G for Complicated Viridans Group Streptococci Bacteremia
por: Wo, Stephanie, et al.
Publicado: (2020)

1376. Oral Vancomycin as Secondary Prophylaxis Against Clostridioides difficile Infection in Pediatric Patients
por: Bao, Hongkai, et al.
Publicado: (2020)

270. Clinical Outcomes of Ceftriaxone versus Penicillin G for Complicated Viridans Group Streptococci Bacteremia
por: Wo, Stephanie, et al.
Publicado: (2020)

Eight Years of Antimicrobial Stewardship Program (ASP) at a Large Academic Medical Center: Antibiotic Utilization, Hospital-onset Clostridium difficile infection (HO-CDI) and Resistance Trends
por: Dubrovskaya, Yanina, et al.
Publicado: (2017)

194 Antimicrobial Stewardship Evaluation of Meropenem Use at a Large Academic Medical Center
por: Dubrovskaya, Yanina, et al.
Publicado: (2014)

2273. Outcomes of Trimethoprim/Sulfamethoxazole as Definitive Therapy for Urinary Tract Infections with Multi-Drug-Resistant Enterobacteriaceae
por: Adhi, Fatima, et al.
Publicado: (2019)

Impact of Streptococcus pneumoniae Urinary Antigen Testing in Patients With Community-Acquired Pneumonia Admitted Within a Large Academic Health System
por: Greenfield, Adam, et al.
Publicado: (2021)

68. Impact of Streptococcus pneumoniae Urinary Antigen Testing in Patients with Community-Acquired Pneumonia Admitted within a Large Academic Medical System
por: Greenfield, Adam, et al.
Publicado: (2021)

Formulation and in vitro characterization of cefpodoxime proxetil gastroretentive microballoons
por: Sharma, AK., et al.
Publicado: (2011)

1651 Role of Metronidazole vs Vancomycin as Initial Therapy in Hospitalized Patients with Mild to Moderate Clostridium difficile Infection (CDI) with NAP1 vs non-NAP1 Disease
por: Dubrovskaya, Yanina, et al.
Publicado: (2014)

Short vs. (vs) Prolonged Course of Therapy for Ventilator-associated Tracheitis (VAT) Caused by Non-lactose-fermenting Gram-negative Rods (NLFGNR) in the Pediatric Intensive Care Unit (PICU)
por: Fong, Karen, et al.
Publicado: (2017)

Efficacy of Cefpodoxime with Clavulanic Acid in the Treatment of Recurrent Pyoderma in Dogs
por: Sudhakara Reddy, B., et al.
Publicado: (2014)

Characterization of impurities in cefpodoxime proxetil using LC–MS(n)
por: Li, Jin, et al.
Publicado: (2014)

Bioequivalence of two tablet formulations of cefpodoxime proxetil in beagle dogs
por: Gao, Yan-Yan, et al.
Publicado: (2022)

Simultaneous RP-HPLC Estimation of Cefpodoxime Proxetil and Clavulanic Acid in Tablets
por: Malathi, S., et al.
Publicado: (2009)

Prospective Cohort Study Investigating the Safety and Efficacy of Ambulatory Treatment With Oral Cefuroxime-Axetil in Febrile Children With Urinary Tract Infection
por: Hennaut, Elise, et al.
Publicado: (2018)

Development and validation of spectrophotometric method of cefpodoxime proxetil using hydrotropic solubilizing agents
por: Asnani, Geet, et al.
Publicado: (2012)

Synthesis, characterization, molecular docking and biological evaluation of Schiff Base derivatives of cefpodoxime
por: Mahmood, Waqas, et al.
Publicado: (2022)

1187. Evaluation of an Antimicrobial Stewardship (AS) Bundle for Uncomplicated Gram-Negative Bloodstream Infections (GN-BSI) in Adults at a Large Academic Health System
por: Dipietro, Juliana M, et al.
Publicado: (2023)

2949. Emergency Department (ED) Discharge Antibiotic Prescription Review by Hospital Pharmacists at a Large Academic Medical Center
por: Dubrovskaya, Yanina, et al.
Publicado: (2023)

Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli
por: Chang, U-Im, et al.
Publicado: (2016)

Hypothyroidism in the “Arnolfini Portrait” (1434) by Jan Van Eyck (1390–1441)
por: Ashrafian, H.
Publicado: (2017)

Development and Validation of RP-HPLC Method for Simultaneous Estimation of Cefpodoxime Proxetil and Dicloxacillin Sodium in Tablets
por: Acharya, D. R., et al.
Publicado: (2013)

2262. Evaluation of Ceftriaxone Versus Cefazolin as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales Isolates
por: Lambert, Kaitlyn, et al.
Publicado: (2023)

Risks of Cefuroxime Prophylaxis for Postcataract Endophthalmitis
por: Al-Abduljabbar, Khaled A., et al.
Publicado: (2017)

Cefuroxime hypersensitivity leading to myocardial ischaemia
por: Tiwari, Rashika, et al.
Publicado: (2022)

Development of HPTLC method for determination of cefpodoxime proxetil and ambroxol hydrochloride in human plasma by liquid–liquid extraction
por: Rote, Ambadas R., et al.
Publicado: (2011)

Worldwide Susceptibility Rates of Neisseria gonorrhoeae Isolates to Cefixime and Cefpodoxime: A Systematic Review and Meta-Analysis
por: Yu, Rui-xing, et al.
Publicado: (2014)

Cefuroxime Axetil (Ceftin(®)): A Brief Review
por: Leder, Rachel Deanne, et al.
Publicado: (1997)

Using intracameral cefuroxime as a prophylaxis for endophthalmitis
por: Yorston, David
Publicado: (2008)

Thermosensitive Nanocomposite Hydrogels for Intravitreal Delivery of Cefuroxime
por: Sapino, Simona, et al.
Publicado: (2019)

Bioequivalence and Population Pharmacokinetic Modeling of Two Forms of Antibiotic, Cefuroxime Lysine and Cefuroxime Sodium, after Intravenous Infusion in Beagle Dogs
por: Zhao, Longshan, et al.
Publicado: (2012)

Efficient Allele-Specific Targeting of LRRK2 R1441 Mutations Mediated by RNAi
por: de Yñigo-Mojado, Laura, et al.
Publicado: (2011)

Transgenic LRRK2(R1441G) rats–a model for Parkinson disease?
por: Shaikh, Komal T., et al.
Publicado: (2015)

Clinical effectiveness and safety of gemifloxacin versus cefpodoxime in acute exacerbation of chronic bronchitis: A randomized, controlled trial
por: Chatterjee, S., et al.
Publicado: (2011)

Formulation and characterization of Cefuroxime Axetil nanoemulsion for improved bioavailability
por: Patel, Yomesh, et al.
Publicado: (2012)

No Resistance to Penicillin, Cefuroxime, Cefotaxime, or Vancomycin in Pneumococcal Pneumonia
por: Yayan, Josef, et al.
Publicado: (2015)

The Impact of Antimicrobial Stewardship Program on Injudicious Use of Cefuroxime
por: Arulappen, Ann L., et al.
Publicado: (2021)

The Impact of Cefuroxime Susceptibility on Aeromonas Necrotizing Fasciitis Outcomes
por: Huang, Tsung-Yu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bisspmamt11ac3249uog4fe3s9